Improved outcome of children with relapsed/refractory acute myeloid leukemia by addition of cladribine to re‐induction chemotherapy

BACKGROUND: The preferred salvage treatment for children with relapsed/refractory acute myeloid leukemia (R/R‐AML) remains unclear. The combination of cladribine/Ara‐C/granulocyte‐colony stimulating factor and mitoxantrone (CLAG‐M) shown promising results in adult R/R‐AML. We aim to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Min, Liu, Li‐Peng, Zhang, Ao‐Li, Quan Qi, Ben, Liu, Fang, Liu, Tian‐Feng, Liu, Xiao‐Ming, Chen, Xiao‐Juan, Yang, Wen‐Yu, Guo, Ye, Zhang, Li, Zou, Yao, Chen, Yu‐Mei, Zhu, Xiao‐Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897947/
https://www.ncbi.nlm.nih.gov/pubmed/33491298
http://dx.doi.org/10.1002/cam4.3681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897947/
https://www.ncbi.nlm.nih.gov/pubmed/33491298
http://dx.doi.org/10.1002/cam4.3681

Ejemplares similares